Education
About Us
Working with TipRanks
Follow Us
HAEMATO AG (DE:HAEK)
HAMBURG:HAEK
HAEK Stock Chart & Stats
Day’s Range― - ―
52-Week Range€10.00 - €17.00
Previous CloseN/A
Volume1.79K
Average Volume (3M)793.00
Market Cap
€52.62M
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta-0.55
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding5,229,307
10 Day Avg. Volume890
30 Day Avg. Volume793
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)0.00
Price to Sales (P/S)0.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
HAEK FAQ
What was HAEMATO AG’s price range in the past 12 months?
HAEMATO AG lowest stock price was €10.00 and its highest was €17.00 in the past 12 months.
What is HAEMATO AG’s market cap?
HAEMATO AG’s market cap is €52.62M.
When is HAEMATO AG’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were HAEMATO AG’s earnings last quarter?
Currently, no data Available
Is HAEMATO AG overvalued?
According to Wall Street analysts HAEMATO AG’s price is currently Overvalued.
Does HAEMATO AG pay dividends?
HAEMATO AG does not currently pay dividends.
What is HAEMATO AG’s EPS estimate?
HAEMATO AG’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does HAEMATO AG have?
HAEMATO AG has 5,229,307 shares outstanding.
What happened to HAEMATO AG’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of HAEMATO AG?
Currently, no hedge funds are holding shares in DE:HAEK
HAEMATO AG Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Company Description
HAEMATO AG
HAEMATO AG is a Germany based pharmaceutical company. It provides pharmaceuticals for the care of chronically ill people. The firm is engaged in the sale of generic and EU (European countries) import drugs. It is focused on patented and non-patented medicinal products. The company product portfolio includes human immunodeficiency virus (HIV), acquired immune deficiency syndrome (AIDS), neurology, oncology, rheumatology, and urology. Geographically, it operates only in Germany.
HAEMATO AG (HAEK) Earnings & Revenues
Currently, no data available
Please return soon. This page is being updated.
Technical Analysis
MeVis Medical Solutions
―
VITA 34
―
APONTIS PHARMA AG
―
DocCheck AG
―
MPH Health Care AG
―